Increased Production of Inflammatory Cytokines after Inoculation with Recombinant Zoster Vaccine in Mice
Sign Up to like & getrecommendations! Published in 2022 at "Vaccines"
DOI: 10.3390/vaccines10081339
Abstract: Increasing numbers of patients with zoster were reported recently, and recombinant zoster vaccine (Shingrix®) was licensed using the AS01B adjuvant system. Although it induces highly effective protection, a high incidence of local adverse events (regional… read more here.
Keywords: day; day first; recombinant zoster; production ... See more keywords